Skip to main content
. 2012 Nov 27;7(11):e50710. doi: 10.1371/journal.pone.0050710

Figure 5. Representative immunohistochemistry staining of paxillin in LSCC.

Figure 5

Positive immunostaining of paxillin mainly in the cytoplasm of tumor cells (pink arrows) and in endothelial cells of microvessels (blue arrows). (A) Negative expression of paxiliin in well-differentiated LSCC. (B) High expression of paxillin in well-differentiated, (C) poorly differentiated, (D) supraglottic, (E) glottic, and (F) subglottic LSCC. (G) Negative control staining (PBS) of paxillin. (Magnification 400×, insets 1000×).